Wang et al. evaluated the association of p53 with the clinical stage, EBV, bcl-2, retinoblastoma gene, p21, Ki67 and topoisomerase-II-alfa and detected p53 gene in 14 patients among the 62 CHL cases. The gene discussed is BCL2; the disease is classic Hodgkin lymphoma.